RESUMEN
The role of lithium as a possible therapeutic strategy for neurodegenerative diseases has generated scientific interest. We systematically reviewed and meta-analyzed pre-clinical and clinical studies that evidenced the neuroprotective effects of lithium in Alzheimer's (AD) and Parkinson's disease (PD). We followed the PRISMA guidelines and performed the systematic literature search using PubMed, EMBASE, Web of Science, and Cochrane Library. A total of 32 articles were identified. Twenty-nine studies were performed in animal models and 3 studies were performed on human samples of AD. A total of 17 preclinical studies were included in the meta-analysis. Our analysis showed that lithium treatment has neuroprotective effects in diseases. Lithium treatment reduced amyloid-ß and tau levels and significantly improved cognitive behavior in animal models of AD. Lithium increased the tyrosine hydroxylase levels and improved motor behavior in the PD model. Despite fewer clinical studies on these aspects, we evidenced the positive effects of lithium in AD patients. This study lends further support to the idea of lithium's therapeutic potential in neurodegenerative diseases.
Asunto(s)
Enfermedad de Alzheimer , Enfermedades Neurodegenerativas , Fármacos Neuroprotectores , Enfermedad de Parkinson , Animales , Humanos , Enfermedad de Parkinson/tratamiento farmacológico , Litio/farmacología , Litio/uso terapéutico , Enfermedad de Alzheimer/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Enfermedades Neurodegenerativas/tratamiento farmacológico , Compuestos de Litio/farmacología , Compuestos de Litio/uso terapéuticoRESUMEN
6-hydroxydopamine (6-OHDA) is a common neurotoxin used to induce Parkinson's disease (PD) in mice, exerting neurotoxic effects through the production of reactive oxygen species and microglial activation. However, the role of microglia in PD is still not clear, with contradictory reports showing neuroprotection or exacerbation of neuronal death. Microglial depletion aggravates motor coordination impairments and reduces tyrosine hydroxylase positive neurons in the substantia nigra pars compacta. Moreover, MeCP2 and Adora1 genes expression were downregulated, suggesting they may be involved in the neurodegenerative process. This study highlights that microglia plays a protective role in dopaminergic neuron survival during the initial phase of PD, and the investigation of the mechanisms of this effect in future studies will help elucidate the pathophysiology of PD.
Asunto(s)
Trastornos Motores , Enfermedad de Parkinson , Ratones , Animales , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/metabolismo , Microglía/metabolismo , Oxidopamina/toxicidad , Oxidopamina/metabolismo , Neuronas Dopaminérgicas/metabolismo , Trastornos Motores/metabolismo , Dopamina , Modelos Animales de Enfermedad , Sustancia Negra/metabolismoRESUMEN
Parkinson's disease (PD) is characterized by motor impairment and dopaminergic neuronal loss. There is no cure for the disease, and treatments have several limitations. The transient receptor potential melastatin 2 (TRPM2), a calcium-permeable non-selective cation channel, has been reported to be upregulated in neuronal death. However, there are no in vivo studies evaluating TRPM2's role and neuroprotective effects in PD. Here, we test the hypothesis that TRPM2 is upregulated in the 6-hydroxydopamine (6-OHDA) mouse model of PD and that its inhibition, by the AG490, is neuroprotective. For that, AG490 or vehicle were intraperitoneally administered into C57BL/6 mice. Mice then received 6-OHDA into the right striatum. Motor behavior assessments were evaluated 6, 13, and 20 days after surgery using the cylinder and apomorphine-induced rotational testes, and 7, 14, and 21 days after surgery using rotarod test. Brain samples of substantia nigra (SNc) and striatum (CPu) were collected for immunohistochemistry and immunoblotting on days 7 and 21. We showed that TRPM2 protein expression was upregulated in 6-OHDA-treated animals. In addition, AG490 prevented dopaminergic neuron loss, microglial activation, and astrocyte reactivity in 6-OHDA-treated animals. The compound improved motor behaviors and Akt/GSK-3ß/caspase-3 signaling. We conclude that TRPM2 inhibition by AG490 is neuroprotective in the 6-OHDA model and that the TRPM2 channel may represent a potential therapeutic target for PD.
Asunto(s)
Fármacos Neuroprotectores , Enfermedad de Parkinson , Canales Catiónicos TRPM , Animales , Modelos Animales de Enfermedad , Neuronas Dopaminérgicas/metabolismo , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Ratones , Ratones Endogámicos C57BL , Fármacos Neuroprotectores/metabolismo , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Oxidopamina/farmacología , Enfermedad de Parkinson/tratamiento farmacológico , Enfermedad de Parkinson/metabolismo , Sustancia Negra/metabolismo , Canales Catiónicos TRPM/metabolismo , TirfostinosRESUMEN
Learning complex motor skills is an essential process in our daily lives. Moreover, it is an important aspect for the development of therapeutic strategies that refer to rehabilitation processes since motor skills previously acquired can be transferred to similar tasks (motor skill transfer) or recovered without further practice after longer delays (motor skill retention). Different acrobatic exercise training (AE) protocols induce plastic changes in areas involved in motor control and improvement in motor performance. However, the plastic mechanisms involved in the retention of a complex motor skill, essential for motor learning, are not well described. Thus, our objective was to analyze the brain plasticity mechanisms involved in motor skill retention in AE . Motor behavior tests, and the expression of synaptophysin (SYP), synapsin-I (SYS), and early growth response protein 1 (Egr-1) in brain areas involved in motor learning were evaluated. Young male Wistar rats were randomly divided into 3 groups: sedentary (SED), AE, and AE with retention period (AER). AE was performed three times a week for 8 weeks, with 5 rounds in the circuit. After a fifteen-day retention interval, the AER animals was again exposed to the acrobatic circuit. Our results revealed motor performance improvement in the AE and AER groups. In the elevated beam test, the AER group presented a lower time and greater distance, suggesting retention period is important for optimizing motor learning consolidation. Moreover, AE promoted significant plastic changes in the expression of proteins in important areas involved in control and motor learning, some of which were maintained in the AER group. In summary, these data contribute to the understanding of neural mechanisms involved in motor learning in an animal model, and can be useful to the construction of therapeutics strategies that optimize motor learning in a rehabilitative context.
Asunto(s)
Encéfalo/fisiología , Aprendizaje/fisiología , Destreza Motora/fisiología , Plasticidad Neuronal/fisiología , Condicionamiento Físico Animal/fisiología , Retención en Psicología/fisiología , Animales , Conducta Animal/fisiología , Encéfalo/metabolismo , Humanos , Masculino , Ratas Wistar , Conducta SedentariaRESUMEN
It is well known that patients with Alzheimer's disease (AD) have imbalances in blood thiamine concentrations and lower activity of thiamine-dependent enzymes. Benfotiamine, a more bioavailable thiamine analog, has been proposed as an alternative to counteract these changes related to thiamine metabolism. Thus, our study aimed to analyze the effects of benfotiamine supplementation on brain thiamine absorption, as well as on parameters related to neuronal energy metabolism and disease progression in an experimental model of sporadic AD induced by intracerebroventricular injection of streptozotocin (STZ) in rats. The supplementation with 150â¯mg/kg of benfotiamine for 30â¯days increased the concentrations of thiamine diphosphate in the hippocampus and entorhinal cortex. This led to an improvement in mitochondria enzymes and insulin signaling pathway, with inactivation of GSK3α/ß and ERK1/2, which are two tau-kinases related to the progression of AD, which could decrease tau hyperphosphorylation and apoptosis signaling. Besides, we observed an increased amount of Glun2b subunit of NMDA receptors, decreased inflammation, and improvement of cognitive deficit. Together, these results suggest that benfotiamine could be a potential therapeutic approach in the treatment of sporadic AD.
Asunto(s)
Enfermedad de Alzheimer , Tiamina Pirofosfato , Enfermedad de Alzheimer/tratamiento farmacológico , Animales , Encéfalo , Cognición , Humanos , Ratas , Tiamina/análogos & derivados , Tiamina/farmacologíaRESUMEN
Parkinson's disease (PD) is typicaly caractherized by loss of dopaminergic neurons, as well as the presence of mitochondrial impairments. Although physical exercise is known to promote many beneficial effects in healthy subjects, such as enhancing mitocondrial biogenesis and function, it is not clear if these effects are evident after exercise in individuals with PD. The aim of this study was to investigate the effects of two different protocol durations on motor behavior (aphomorphine and gait tests), mitochondrial biogenesis signaling (PGC-1α, NRF-1 and TFAM), structure (oxidative phosphorylation system protein levels) and respiratory chain activity (complex I) in a unilateral PD rat model. For this, male Wistar rats were injected with 6-hydroxydopamine unilaterally into the striatum and submitted to an intermitent moderate treadmill exercise for one or four weeks. In the gait test, only stride width data revealed an improvement after one week of exercise. On the other hand, after 4 weeks of the exercise protocol all gait parameters analyzed and the aphomorphine test demonstrated a recovery. Analysis of protein revealed that one week of exercise was able to prevent PGC-1α and NRF-1 expression decrease in PD animals. In addition, after four weeks of physical exercise, besides PGC-1α and NRF-1, reduction in TFAM and complex I protein levels and increased complex I activity were also prevented in PD animals. Thus, our results suggest a neuroprotective and progressive effect of intermittent treadmill exercise, which could be related to its benefits on mitochondrial biogenesis signaling and respiratory chain modulation of the dopaminergic system in PD.
Asunto(s)
Mitocondrias/metabolismo , Trastornos Parkinsonianos/metabolismo , Trastornos Parkinsonianos/fisiopatología , Condicionamiento Físico Animal , Animales , Modelos Animales de Enfermedad , Neuronas Dopaminérgicas/metabolismo , Marcha , Masculino , Estrés Oxidativo/efectos de los fármacos , Oxidopamina/administración & dosificación , Trastornos Parkinsonianos/inducido químicamente , Trastornos Parkinsonianos/prevención & control , Porción Compacta de la Sustancia Negra/patología , Ratas Wistar , Transducción de SeñalRESUMEN
Impairment of mitochondrial biogenesis and mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD). However, the extent to which the impairment of mitochondrial biogenesis influences mitochondrial dysfunction at the onset and during progression of AD is still unclear. Our study demonstrated that the protein expression pattern of the transcription factor pCREB/CREB, together with the protein expression of PGC-1α, NRF1 and TFAM are all significantly reduced in early ages of 3xTg-AD mice. We also found reduced mRNA expression levels of PKAC-α, CREB, PGC-1α, NRF1, NRF2 and TFAM as early as 1 month-of-age, an age at which there was no significant Aß oligomer deposition, suggesting that mitochondrial biogenesis is likely impaired in ages preceding the development of the AD pathology. In addition, there was a decrease in VDAC2 expression, which is related to mitochondrial content and mitochondrial function, as demonstrated by protein expression of complex IV, as well as complex II + III, and complex IV activities, at later ages in 3xTg-AD mice. These results suggest that the impairment in mitochondrial biogenesis signaling mediated by PGC-1α at early ages of the AD mice model likely resulted in mitochondrial dysfunction and manifestation of the AD pathology at later ages. Taken together, enhancing mitochondrial biogenesis may represent a potential pharmacological approach for the treatment of AD.
Asunto(s)
Enfermedad de Alzheimer , Biogénesis de Organelos , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/metabolismo , Enfermedad de Alzheimer/genética , Animales , Complejo IV de Transporte de Electrones/metabolismo , Ratones , Mitocondrias/metabolismo , Coactivador 1-alfa del Receptor Activado por Proliferadores de Peroxisomas gamma/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismoRESUMEN
Recently, it has been suggested that oxytocin (OT) might play a role in the control of bone remodeling and in bone health of young and adult females. The purpose of this study was to evaluate the effect of osteogenic medium (OM) plus OT (OMâ¯+â¯OT; 100â¯nmol/L) on osteoblastic differentiation of bone marrow mesenchymal stem cells (BMMSCs) from cyclic adult (12â¯months old) and acyclic aging (24â¯months old) female Wistar rats. After 14â¯days, OMâ¯+â¯OT increased the oxytocin and oxytocin receptor in the BMMSCs from animals of both age groups relative to OM controls. Alkaline phosphatase activity was higher in the OMâ¯+â¯OT than OM group in BMMSCs from 24-month-old female rats. OMâ¯+â¯OT improved osteogenic differentiation, observed by anticipated mineralization and increased gene expression of bone morphogenetic protein 2, bone sialoprotein, osteopontin and osteocalcin in both aged relative to OM controls. These findings suggest a role for OT as an adjuvant to induce osteoblastic differentiation of BMMSCs from aged female rat.
Asunto(s)
Envejecimiento , Células Madre Mesenquimatosas/citología , Osteoblastos/citología , Osteogénesis/efectos de los fármacos , Oxitocina/farmacología , Fosfatasa Alcalina/metabolismo , Animales , Proteína Morfogenética Ósea 2/metabolismo , Diferenciación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Células Madre Mesenquimatosas/efectos de los fármacos , Ratas , Ratas WistarRESUMEN
The effects of strength training (ST) on the mechanical bone strength and osteogenic differentiation of bone marrow mesenchymal stromal cells (BMSCs) from adult, aged and exercised aged rats were determined. The exercised aged animals displayed higher values of areal bone mineral density, compression test, alkaline phosphatase activity (ALP) and biological mineralization, while oil red O staining for adipocytes was lower. ST increased gene expression of runt-related transcription factor 2 (Runx2), osterix (Osx) as well as bone matrix protein expression, and reduced expression of peroxisome proliferator-activated receptor gamma (Pparγ). The production of pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α) was lower in BMSCs of the aged exercised group. The ST practice was able to improve the bone mechanical properties in aged female rats, increasing the potential for osteogenic differentiation of BMSCs, reducing the adipogenic differentiation and pro-inflammatory cytokine level. In summary, the data achieved in this study showed that strength training triggers physiological responses that result in changes in the bone microenvironment and bring benefits to biomechanical parameters of bone tissue, which could reduce the risk of fractures during senescent.
Asunto(s)
Envejecimiento/fisiología , Huesos/fisiología , Osteogénesis , Entrenamiento de Fuerza/métodos , Envejecimiento/metabolismo , Animales , Biomarcadores/metabolismo , Fenómenos Biomecánicos , Peso Corporal , Densidad Ósea , Células de la Médula Ósea/citología , Diferenciación Celular , Células Cultivadas , Femenino , Ratas , Ratas WistarRESUMEN
The aim of this study was to investigate the effects of strength training (ST) and raloxifene (Ral), alone or in combination, on the prevention of bone loss in an aging estrogen-deficient rat model. Aging Wistar female rats were ovariectomized at 14months and allocated to four groups: (1) non-trained and treated with vehicle, NT-Veh; (2) strength training and treated with vehicle, ST-Veh; (3) non-trained and treated with raloxifene, NT-Ral; and (4) strength training and treated with raloxifene, ST-Ral. ST was performed on a ladder three times per week and Ral was administered daily by gavage (1mg/kg/day), both for 120days. Areal bone mineral density (aBMD), strength, microarchitecture, and biomarkers (osteocalcin, OCN; osteoprotegerin, OPG; and tartrate-resistant acid phosphatase, TRAP) were assessed. Immunohistochemistry was performed for runt-related transcription factor 2 (RUNX2), osterix (OSX), OCN, OPG, TRAP, and receptor activator of nuclear factor kappa-B ligand (RANKL). The rats that performed ST (ST-Veh) or were treated with Ral (NT-Ral) showed significant improvements in aBMD (p=0.001 and 0.004), bone strength (p=0.001), and bone microarchitecture, such as BV/TV (%) (p=0.001), BS/TV (mm(2)/mm(3)) (p=0.023 and 0.002), Conn.Dn (1/mm(3)) (p=0.001), Tb.N (1/mm) (p=0.012 and 0.011), Tb.Th (1/mm) (p=0.001), SMI (p=0.001 and 0.002), Tb.Sp (p=0.001), and DA (p=0.002 and 0.007); there was also a significant decrease in plasma levels of OCN (p=0.001 and 0.002) and OPG (p=0.003 and 0.014), compared with animals in the NT-Veh group. Ral, with or without ST, promoted an increased immunolabeling pattern for RUNX2 (p=0.0105 and p=0.0006) and OSX (p=0.0105), but a reduced immunolabeling pattern for TRAP (p=0.0056) and RANKL (p=0.033 and 0.004). ST increased the immunolabeling pattern for RUNX2 (p=0.0105), and association with Ral resulted in an increased immunolabeling pattern for OPG (p=0.0034) and OCN (p=0.0024). In summary, ST and Ral administration in aged, estrogen-deficient Wistar female rats is associated with a decrease in bone turnover marker plasma levels, increased activity of cells that promote osteoblastogenesis, and decreased activity of cells that promote osteoclastogenesis; these are correlated with higher aBMD, bone strength, and bone microarchitecture at the femoral neck. The results indicate that strength training and Ral are potential tools to reduce the risk of fractures at clinically relevant sites.
Asunto(s)
Envejecimiento/fisiología , Huesos/fisiología , Ovariectomía , Clorhidrato de Raloxifeno/farmacología , Entrenamiento de Fuerza , Animales , Biomarcadores/sangre , Peso Corporal/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Remodelación Ósea/efectos de los fármacos , Huesos/efectos de los fármacos , Estradiol/sangre , Femenino , Fémur/efectos de los fármacos , Imagenología Tridimensional , Tamaño de los Órganos/efectos de los fármacos , Ratas Wistar , Útero/efectos de los fármacosRESUMEN
Células tronco mesenquimais (CTMs) derivadas do estroma da medula óssea possuem potencial para se diferenciar in vivo e in vitro, em vários tipos celulares, incluindo osteoblastos e adipócitos. Durante o envelhecimento, há o maior número de células que se diferenciam espontaneamente em adipócitos, comprometendo a qualidade óssea, bem como perda da massa óssea decorrente do estilo de vida sedentário. Dentre fatores capazes de modular a diferenciação de CTMs em prol a formação óssea, sinais mecânicos estão sendo estudados como alternativa para o tratamento da osteoporose. Neste estudo, analisamos como o treinamento de força (TF) influencia a remodelação óssea durante o envelhecimento. Para isso, analisamos o potencial osteogênico de diferenciação de CTMs isoladas da medula óssea de ratas adultas (09 meses) e idosas (21 meses) que realizaram ou não o exercício físico com sobrecarga. Os resultados mostraram que o TF aumentou a expressão da proteína óssea morfogênica 2 (BMP2), regulando a diferenciação dos osteoblastos e formação óssea por promover up-regulation do fator de transcrição relacionado com o Runt 2 (Runx2) e down-regulation do fator de transcrição de adipócitos, receptor ativado por proliferadores de peroxissoma γ (Pparγ) em CTMs diferenciadas de doadoras idosas. Além disso, os valores de densidade mineral óssea areal e os parâmetros biomecânicos na tíbia das ratas idosas foram otimizados após a realização do TF. Estes resultados sugerem que o aumento dos fatores de transcrição e proteínas de matriz, bem como o decréscimo de Pparγ, desencadeado pelo TF, contribui para a melhoria da qualidade do osso de ratas idosas treinadas...
In vivo and in vitro studies indicate that a subpopulation of bone marrow stromal cells derived mesenchymal stem cells (MSCs) has potential to differentiate into multiple cell types, including osteoblasts and adipocytes. During the aging, greater number of cells is able to differentiate spontaneously into adipocytes, committing bone quality, well as loss of bone mass due to the sedentary lifestyle. Among the factors capable of modulating differentiation of MSCs to promote bone formation mechanical signals are being studied as an alternative for the treatment of osteoporosis. In this study, we analyzed how the strength training (ST) participates in the bone remodeling during the aging. For this purpose, we analyzed the osteogenic potential of differentiation of MSCs isolated from the bone marrow of adult (09 months) and elderly (21 months) female rats that performed or not physical activity with overcharge. The results showed that the ST increased the bone morphogenic protein 2 (BMP2), regulated the osteoblast differentiation and bone formation for up-regulation of the osteogenic master transcription factor, Runt-related transcription factor 2 (Runx2) and the down-regulation of the adipocytes master transcription factor, peroxisome proliferator-activated receptor γ (Pparγ) in differentiated MSCs of the elderly donors. In addition, the values of areal bone mineral density and biomechanical parameters in the tibia of elderly rats were optimized after the realization of ST. These results suggest that increase of transcription factors and matrix proteins as well as the decrease of Pparγ, triggered by ST, contributes to better bone quality of trained elderly...